MA26117A1 - Nouveau compose pour le traitement de l'impuissance - Google Patents

Nouveau compose pour le traitement de l'impuissance

Info

Publication number
MA26117A1
MA26117A1 MA27465A MA27465A MA26117A1 MA 26117 A1 MA26117 A1 MA 26117A1 MA 27465 A MA27465 A MA 27465A MA 27465 A MA27465 A MA 27465A MA 26117 A1 MA26117 A1 MA 26117A1
Authority
MA
Morocco
Prior art keywords
impotence
treatment
new compound
compound
new
Prior art date
Application number
MA27465A
Other languages
English (en)
Inventor
Baoshun Liu
Original Assignee
Baoshun Liu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25740515&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA26117(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baoshun Liu filed Critical Baoshun Liu
Publication of MA26117A1 publication Critical patent/MA26117A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA27465A 2001-06-29 2003-12-26 Nouveau compose pour le traitement de l'impuissance MA26117A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN01129691 2001-06-29
CN02100198A CN1127506C (zh) 2001-06-29 2002-01-18 一种治疗阳痿的新化合物

Publications (1)

Publication Number Publication Date
MA26117A1 true MA26117A1 (fr) 2004-04-01

Family

ID=25740515

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27465A MA26117A1 (fr) 2001-06-29 2003-12-26 Nouveau compose pour le traitement de l'impuissance

Country Status (18)

Country Link
US (1) US6960592B2 (fr)
EP (1) EP1400522B1 (fr)
JP (1) JP4469174B2 (fr)
KR (1) KR100878739B1 (fr)
CN (1) CN1127506C (fr)
AU (1) AU2002323774B2 (fr)
BR (1) BRPI0211025B8 (fr)
CA (1) CA2451990C (fr)
CY (1) CY1115687T1 (fr)
DK (1) DK1400522T3 (fr)
ES (1) ES2519441T3 (fr)
IL (1) IL159386A0 (fr)
MA (1) MA26117A1 (fr)
MX (1) MXPA03011929A (fr)
NZ (1) NZ530548A (fr)
PT (1) PT1400522E (fr)
RU (1) RU2279433C2 (fr)
WO (1) WO2003016313A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100360531C (zh) * 2003-12-18 2008-01-09 中国人民解放军军事医学科学院放射与辐射医学研究所 用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物
WO2007141805A2 (fr) * 2006-06-05 2007-12-13 Matrix Laboratories Limited Nouveau procédé de préparation du citrate de sildénafil
CN101914100B (zh) * 2010-04-13 2013-01-30 漆又毛 苯磺酰基二甲基哌嗪衍生物及制备方法
CN101891747B (zh) * 2010-07-02 2012-04-25 张南 抑制5型磷酸二酯酶的化合物及制备方法
CN109970744A (zh) * 2019-04-10 2019-07-05 重庆康刻尔制药有限公司 一种枸橼酸西地那非中间体的合成方法
CN112745323B (zh) * 2020-12-30 2021-10-29 北京悦康科创医药科技股份有限公司 枸橼酸爱地那非晶型h及其制备方法和用途
CN113350301B (zh) * 2021-06-03 2022-10-04 刘宝顺 一种治疗阳痿的新化合物中药蜜丸
WO2023109513A1 (fr) 2021-12-14 2023-06-22 真奥金银花药业有限公司 Utilisation de sildénafil ou d'un sel de celui-ci dans la préparation d'un médicament pour la prévention ou le traitement d'une lésion cérébrale ischémique
KR102580664B1 (ko) 2023-01-25 2023-09-21 (주)나인팩토리커뮤니케이션 남성 성기에 부종감 및 온열감을 주고 혈행을 개선하는 피부 외용제 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
US5250534A (en) * 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US6200980B1 (en) * 1995-06-07 2001-03-13 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl purinone derivatives
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
WO1999062905A1 (fr) * 1998-06-03 1999-12-09 Almirall Prodesfarma, S.A. Derives de 8-phenylxanthine et leur utilisation en tant qu'inhibiteurs de phosphodiesterase
ES2166270B1 (es) 1999-07-27 2003-04-01 Almirall Prodesfarma Sa Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona.

Also Published As

Publication number Publication date
US20040152709A1 (en) 2004-08-05
BRPI0211025B1 (pt) 2016-03-01
NZ530548A (en) 2005-04-29
RU2004102513A (ru) 2005-03-27
KR20040010779A (ko) 2004-01-31
EP1400522A4 (fr) 2006-04-05
CA2451990C (fr) 2008-06-17
US6960592B2 (en) 2005-11-01
EP1400522A1 (fr) 2004-03-24
AU2002323774B2 (en) 2007-10-25
JP4469174B2 (ja) 2010-05-26
RU2279433C2 (ru) 2006-07-10
WO2003016313A1 (fr) 2003-02-27
JP2005500381A (ja) 2005-01-06
BRPI0211025B8 (pt) 2021-05-25
DK1400522T3 (da) 2014-11-10
CY1115687T1 (el) 2017-01-25
EP1400522B1 (fr) 2014-08-06
CN1393444A (zh) 2003-01-29
MXPA03011929A (es) 2005-03-07
CA2451990A1 (fr) 2003-02-27
CN1127506C (zh) 2003-11-12
IL159386A0 (en) 2004-06-01
PT1400522E (pt) 2014-10-30
KR100878739B1 (ko) 2009-01-14
ES2519441T3 (es) 2014-11-07
BR0211025A (pt) 2004-10-19

Similar Documents

Publication Publication Date Title
FR15C0070I2 (fr) Composes heteroaromatiques azotes pour le traitement des maladies de cancer
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
MA26822A1 (fr) Composes pour le traitement d'une ischemie.
MA25823A1 (fr) Compositions pour le traitement de l'eau.
EE200200716A (et) Ühendid Alzheimeri tõve käitluseks
IL160990A0 (en) Spiro-hydantoin compounds useful as anti-inflammatory agents
ATE551340T1 (de) Azabicyclisch- substituierte annelierte heteroaryl-verbinungen für die behandlung von krankheiten
EP1390029A4 (fr) Phenylindoles pour le traitement de l'infection par le vih
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
FR2829142B1 (fr) Composition filmogene d'heteroxylanes pour la fabrication de capsules ainsi obtenues
IL162485A0 (en) Compounds for the treatment of inflammatory disorders
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
FR13C0044I2 (fr) Utilisation de dihydroimidazolones pour le traitement de l'epilepsie canine
MA26950A1 (fr) Nouveaux retinoides pour le traitement de l'emphyseme
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
MA26117A1 (fr) Nouveau compose pour le traitement de l'impuissance
EP1461030A4 (fr) Composes d'aminoalkyl-benzofuran-5-ol pour le traitement du glaucome
HUP0402341A3 (en) Compositions containing thiazol-2-ylamines for the treatment of cancer
FR2835851B1 (fr) Composition pour le traitement d'alliages de magnesium
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires
FR2758465B1 (fr) Composition pour le traitement de l'amiante
IL162455A0 (en) Compounds for the treatment of sexual dysfunction
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
MA26830A1 (fr) Pyrroles substituees utilisees en tant qu'agents anti-proliferants pour le traitement du cancer
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser